Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer [Phase 2]
Phase 2 trial evaluating bicalutamide with or without the Akt inhibitor MK-2206 in previously treated prostate cancer has posted results. Th…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy [Phase 2]
Phase 2 clinical trial investigating vitamin D in men undergoing prostatectomy for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence [Phase 2, Phase 3]
Clinical trial update on Gallium-68 PSMA-11 PET imaging in patients with biochemical recurrence of prostate cancer (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Cardiovascular Events in GnRH Agonist vs. Antagonist [Phase 2]
Phase 2 trial update comparing GnRH agonist vs antagonist with a focus on cardiovascular events in prostate cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning [NA]
Clinical trial update on incorporating MR imaging into prostate radiotherapy treatment planning; trial completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-11-26Clinical Trial Update: Functional MRI Use in Prostate Radiation Treatment Planning [NA]
Clinical trial update evaluating functional MRI use in planning radiation therapy for prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a [NA]
Clinical trial update on genomic-targeted chemoprevention for prostate cancer, completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer [Phase 3]
Phase 3 trial evaluating a subcutaneous four-month sustained-release formulation of triptorelin in prostate cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial update for ABI-008 in hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC) [Phase 2]
Phase 2 trial update evaluating intermittent chemotherapy with or without GM-CSF in metastatic hormone-refractory prostate cancer; results p…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Therapeutics in Active Prostate Cancer Surveillance [Phase 2]
Phase 2 clinical trial update for therapeutics in active prostate cancer surveillance has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: A Research Study for Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial update for patients with prostate cancer, including metastatic cases, completed.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating natural dendritic cells for immunotherapy in chemo-naive metastatic castration-resistant prostate cancer has comple…
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update for Lutetium-177-PSMA-617 in low-volume metastatic prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating a vaccine therapy for recurrent prostate cancer has completed.
-
FDA approval · 2019-11-04FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approves Amneal Pharmaceuticals NY LLC's supplemental application for Abiraterone acetate, authorizing the manufacture and sale of a gen…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial of Paclitaxel and Bryostatin 1 in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial assessing combination chemotherapy with peripheral stem cell transplantation for metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer [Phase 3]
Phase 3 trial evaluating darolutamide in high-risk non-metastatic castration-resistant prostate cancer has completed with posted results in …
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Phase I/II Hypofractionated Radiotherapy for Prostate Cancer [Phase 1, Phase 2]
Phase I/II trial investigating hypofractionated radiotherapy for prostate cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC) [Phase 1]
Phase 1 trial update investigating enzalutamide and niraparib for metastatic castration-resistant prostate cancer (CRPC) has been terminated…
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 pilot study of PLX3397 in advanced castration-resistant prostate cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 trial comparing interstitial brachytherapy with or without external-beam radiation therapy for prostate cancer has completed. Result…
-
FDA approval · 2019-10-16FDA Approved: ABIRATERONE ACETATE — Original Application (NORTHSTAR RX LLC)
FDA approved the original ANDA for abiraterone acetate submitted by NorthStar RX LLC.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Ipilimumab + Androgen Depravation Therapy in Prostate Cancer [Phase 2]
Phase 2 trial update on ipilimumab combined with androgen deprivation therapy in prostate cancer; study terminated with posted results.